Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for subject:(Mod lisation PK PD). Showing records 1 – 30 of 996 total matches.

[1] [2] [3] [4] [5] … [34]

Search Limiters

Last 2 Years | English Only

Degrees

Levels

Languages

Country

▼ Search Limiters

1. Macaire, Pauline. Modélisation par une approche de population de l’effet des facteurs de croissance granulocytaire lors de neutropénies chimio-induites : A modelling population-based approach to the effect of granulocyte growth factors during chemotherapy-induced neutropenia.

Degree: Docteur es, Pharmacie, 2020, Bourgogne Franche-Comté

Les travaux de cette thèse s'appuient sur les résultats d'une étude de cohorte ayant pour objectif principal de définir le schéma optimal d'administration prophylactique des… (more)

Subjects/Keywords: Modélisation PK/PD; Cancers digestifs; Neutropénies; Monolix; PK/PD modeling; Digestive cancer; Neutropenia; Monolix; 615

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Macaire, P. (2020). Modélisation par une approche de population de l’effet des facteurs de croissance granulocytaire lors de neutropénies chimio-induites : A modelling population-based approach to the effect of granulocyte growth factors during chemotherapy-induced neutropenia. (Doctoral Dissertation). Bourgogne Franche-Comté. Retrieved from http://www.theses.fr/2020UBFCJ001

Chicago Manual of Style (16th Edition):

Macaire, Pauline. “Modélisation par une approche de population de l’effet des facteurs de croissance granulocytaire lors de neutropénies chimio-induites : A modelling population-based approach to the effect of granulocyte growth factors during chemotherapy-induced neutropenia.” 2020. Doctoral Dissertation, Bourgogne Franche-Comté. Accessed January 16, 2021. http://www.theses.fr/2020UBFCJ001.

MLA Handbook (7th Edition):

Macaire, Pauline. “Modélisation par une approche de population de l’effet des facteurs de croissance granulocytaire lors de neutropénies chimio-induites : A modelling population-based approach to the effect of granulocyte growth factors during chemotherapy-induced neutropenia.” 2020. Web. 16 Jan 2021.

Vancouver:

Macaire P. Modélisation par une approche de population de l’effet des facteurs de croissance granulocytaire lors de neutropénies chimio-induites : A modelling population-based approach to the effect of granulocyte growth factors during chemotherapy-induced neutropenia. [Internet] [Doctoral dissertation]. Bourgogne Franche-Comté; 2020. [cited 2021 Jan 16]. Available from: http://www.theses.fr/2020UBFCJ001.

Council of Science Editors:

Macaire P. Modélisation par une approche de population de l’effet des facteurs de croissance granulocytaire lors de neutropénies chimio-induites : A modelling population-based approach to the effect of granulocyte growth factors during chemotherapy-induced neutropenia. [Doctoral Dissertation]. Bourgogne Franche-Comté; 2020. Available from: http://www.theses.fr/2020UBFCJ001


University of Oxford

2. Hutton-Smith, Laurence. Modelling the pharmacokinetics and pharmacodynamics of macromolecules for the treatment of wet AMD.

Degree: PhD, 2018, University of Oxford

 Wet age related macular degeneration (wet AMD) is a highly debilitating retinal disease, the third leading cause of blindness in the world and one the… (more)

Subjects/Keywords: 510; PK/PD; wet amd; IVT injection; mathematical modelling

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Hutton-Smith, L. (2018). Modelling the pharmacokinetics and pharmacodynamics of macromolecules for the treatment of wet AMD. (Doctoral Dissertation). University of Oxford. Retrieved from http://ora.ox.ac.uk/objects/uuid:5c6d908f-ebf1-4006-8666-862a17c3f799 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.757871

Chicago Manual of Style (16th Edition):

Hutton-Smith, Laurence. “Modelling the pharmacokinetics and pharmacodynamics of macromolecules for the treatment of wet AMD.” 2018. Doctoral Dissertation, University of Oxford. Accessed January 16, 2021. http://ora.ox.ac.uk/objects/uuid:5c6d908f-ebf1-4006-8666-862a17c3f799 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.757871.

MLA Handbook (7th Edition):

Hutton-Smith, Laurence. “Modelling the pharmacokinetics and pharmacodynamics of macromolecules for the treatment of wet AMD.” 2018. Web. 16 Jan 2021.

Vancouver:

Hutton-Smith L. Modelling the pharmacokinetics and pharmacodynamics of macromolecules for the treatment of wet AMD. [Internet] [Doctoral dissertation]. University of Oxford; 2018. [cited 2021 Jan 16]. Available from: http://ora.ox.ac.uk/objects/uuid:5c6d908f-ebf1-4006-8666-862a17c3f799 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.757871.

Council of Science Editors:

Hutton-Smith L. Modelling the pharmacokinetics and pharmacodynamics of macromolecules for the treatment of wet AMD. [Doctoral Dissertation]. University of Oxford; 2018. Available from: http://ora.ox.ac.uk/objects/uuid:5c6d908f-ebf1-4006-8666-862a17c3f799 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.757871


Universidad Nacional de La Plata

3. Meneses, María Laura. Desarrollo de un modelo experimental para el estudio <i>in vivo</i> de la farmacodinamia de los antimicrobianos.

Degree: 2013, Universidad Nacional de La Plata

En la actualidad, la CIM asume un papel fundamental en el cálculo de los parámetros farmacocinéticos/farmacodinámicos, T>CIM; AUC/CIM y Cmax/CIM, considerados como predictores de la… (more)

Subjects/Keywords: Ciencias Veterinarias; Cefalexina; farmacodinamia; Farmacocinética; antimicrobianos; PK/PD; Ciprofloxacino; Farmacia

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Meneses, M. L. (2013). Desarrollo de un modelo experimental para el estudio <i>in vivo</i> de la farmacodinamia de los antimicrobianos. (Thesis). Universidad Nacional de La Plata. Retrieved from http://sedici.unlp.edu.ar/handle/10915/45025 ; https://doi.org/10.35537/10915/45025

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Meneses, María Laura. “Desarrollo de un modelo experimental para el estudio <i>in vivo</i> de la farmacodinamia de los antimicrobianos.” 2013. Thesis, Universidad Nacional de La Plata. Accessed January 16, 2021. http://sedici.unlp.edu.ar/handle/10915/45025 ; https://doi.org/10.35537/10915/45025.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Meneses, María Laura. “Desarrollo de un modelo experimental para el estudio <i>in vivo</i> de la farmacodinamia de los antimicrobianos.” 2013. Web. 16 Jan 2021.

Vancouver:

Meneses ML. Desarrollo de un modelo experimental para el estudio <i>in vivo</i> de la farmacodinamia de los antimicrobianos. [Internet] [Thesis]. Universidad Nacional de La Plata; 2013. [cited 2021 Jan 16]. Available from: http://sedici.unlp.edu.ar/handle/10915/45025 ; https://doi.org/10.35537/10915/45025.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Meneses ML. Desarrollo de un modelo experimental para el estudio <i>in vivo</i> de la farmacodinamia de los antimicrobianos. [Thesis]. Universidad Nacional de La Plata; 2013. Available from: http://sedici.unlp.edu.ar/handle/10915/45025 ; https://doi.org/10.35537/10915/45025

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Minnesota

4. Basu, Cynthia. Bayesian Hierarchical Models for Data Extrapolation and Analysis in Rare and Pediatric Disease Clinical Trials.

Degree: PhD, Biostatistics, 2017, University of Minnesota

 A rare disease is defined by the Rare Diseases Act of 2002 as a disease that currently affects fewer than 200,000 patients in the USA.… (more)

Subjects/Keywords: Bayesian Hierarchical Models; Clinical Trials; Data Extrapolation; PK/PD

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Basu, C. (2017). Bayesian Hierarchical Models for Data Extrapolation and Analysis in Rare and Pediatric Disease Clinical Trials. (Doctoral Dissertation). University of Minnesota. Retrieved from http://hdl.handle.net/11299/191398

Chicago Manual of Style (16th Edition):

Basu, Cynthia. “Bayesian Hierarchical Models for Data Extrapolation and Analysis in Rare and Pediatric Disease Clinical Trials.” 2017. Doctoral Dissertation, University of Minnesota. Accessed January 16, 2021. http://hdl.handle.net/11299/191398.

MLA Handbook (7th Edition):

Basu, Cynthia. “Bayesian Hierarchical Models for Data Extrapolation and Analysis in Rare and Pediatric Disease Clinical Trials.” 2017. Web. 16 Jan 2021.

Vancouver:

Basu C. Bayesian Hierarchical Models for Data Extrapolation and Analysis in Rare and Pediatric Disease Clinical Trials. [Internet] [Doctoral dissertation]. University of Minnesota; 2017. [cited 2021 Jan 16]. Available from: http://hdl.handle.net/11299/191398.

Council of Science Editors:

Basu C. Bayesian Hierarchical Models for Data Extrapolation and Analysis in Rare and Pediatric Disease Clinical Trials. [Doctoral Dissertation]. University of Minnesota; 2017. Available from: http://hdl.handle.net/11299/191398


Georgia Tech

5. Wei, Xin. Medical decision making - a personalized approach.

Degree: PhD, Industrial and Systems Engineering, 2018, Georgia Tech

 One of the challenges in medical decision making is the complexity, variability and uncertainty that exist in both patients and different treatment methods. In real… (more)

Subjects/Keywords: Personalized medicine; Diabetes; PK/PD; Radiotherapy; Direct aperture optimization

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Wei, X. (2018). Medical decision making - a personalized approach. (Doctoral Dissertation). Georgia Tech. Retrieved from http://hdl.handle.net/1853/61652

Chicago Manual of Style (16th Edition):

Wei, Xin. “Medical decision making - a personalized approach.” 2018. Doctoral Dissertation, Georgia Tech. Accessed January 16, 2021. http://hdl.handle.net/1853/61652.

MLA Handbook (7th Edition):

Wei, Xin. “Medical decision making - a personalized approach.” 2018. Web. 16 Jan 2021.

Vancouver:

Wei X. Medical decision making - a personalized approach. [Internet] [Doctoral dissertation]. Georgia Tech; 2018. [cited 2021 Jan 16]. Available from: http://hdl.handle.net/1853/61652.

Council of Science Editors:

Wei X. Medical decision making - a personalized approach. [Doctoral Dissertation]. Georgia Tech; 2018. Available from: http://hdl.handle.net/1853/61652

6. Giraud, Cristina Sanches. Abordagem farmacocinética e farmacodinâmica no monitoramento terapêutico de antimicrobianos em pacientes queimados da unidade de terapia intensiva.

Degree: PhD, Produção e Controle Farmacêuticos, 2011, University of São Paulo

 Introdução: A sepse é a maior causa de morbidade e mortalidade em pacientes queimados, uma vez que profundas alterações ocorrem na farmacocinética de agentes antimicrobianos… (more)

Subjects/Keywords: Burns; Control of infections; Controle das infecções; Dose adjusted therapy; Drug plasma monitoring; Modelagem farmacocinética; Monitoramento plasmático; Pharmacokinetics; PK-PD; PK-PD modeling; Queimados; Sepse; Sepsis; Terapia dose ajustada

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Giraud, C. S. (2011). Abordagem farmacocinética e farmacodinâmica no monitoramento terapêutico de antimicrobianos em pacientes queimados da unidade de terapia intensiva. (Doctoral Dissertation). University of São Paulo. Retrieved from http://www.teses.usp.br/teses/disponiveis/9/9139/tde-26102011-112130/ ;

Chicago Manual of Style (16th Edition):

Giraud, Cristina Sanches. “Abordagem farmacocinética e farmacodinâmica no monitoramento terapêutico de antimicrobianos em pacientes queimados da unidade de terapia intensiva.” 2011. Doctoral Dissertation, University of São Paulo. Accessed January 16, 2021. http://www.teses.usp.br/teses/disponiveis/9/9139/tde-26102011-112130/ ;.

MLA Handbook (7th Edition):

Giraud, Cristina Sanches. “Abordagem farmacocinética e farmacodinâmica no monitoramento terapêutico de antimicrobianos em pacientes queimados da unidade de terapia intensiva.” 2011. Web. 16 Jan 2021.

Vancouver:

Giraud CS. Abordagem farmacocinética e farmacodinâmica no monitoramento terapêutico de antimicrobianos em pacientes queimados da unidade de terapia intensiva. [Internet] [Doctoral dissertation]. University of São Paulo; 2011. [cited 2021 Jan 16]. Available from: http://www.teses.usp.br/teses/disponiveis/9/9139/tde-26102011-112130/ ;.

Council of Science Editors:

Giraud CS. Abordagem farmacocinética e farmacodinâmica no monitoramento terapêutico de antimicrobianos em pacientes queimados da unidade de terapia intensiva. [Doctoral Dissertation]. University of São Paulo; 2011. Available from: http://www.teses.usp.br/teses/disponiveis/9/9139/tde-26102011-112130/ ;

7. Djabarouti, Sarah. Optimisation des traitements à base d'acide mycophénolique chez les patients atteints de maladies auto-immunes : Strategies for improving treatments with mycophenolic acid in patients with autoimmune diseases.

Degree: Docteur es, Sciences, technologie, santé. Pharmacologie, 2009, Université de Bordeaux Segalen

L’acide mycophénolique (MPA) est un immunosuppresseur très prometteur dans le traitement des maladies auto-immunes (MAI) telles que le lupus érythémateux disséminé (LED) et les vascularites… (more)

Subjects/Keywords: Acide mycophénolique; Corrélations PK/PD; Lupus érythémateux disséminé; Vascularites à ANCA; Mycophenolic acid; PK/PD relationships; Systemic lupus erythematosus; ANCA-associated vasculitis

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Djabarouti, S. (2009). Optimisation des traitements à base d'acide mycophénolique chez les patients atteints de maladies auto-immunes : Strategies for improving treatments with mycophenolic acid in patients with autoimmune diseases. (Doctoral Dissertation). Université de Bordeaux Segalen. Retrieved from http://www.theses.fr/2009BOR21699

Chicago Manual of Style (16th Edition):

Djabarouti, Sarah. “Optimisation des traitements à base d'acide mycophénolique chez les patients atteints de maladies auto-immunes : Strategies for improving treatments with mycophenolic acid in patients with autoimmune diseases.” 2009. Doctoral Dissertation, Université de Bordeaux Segalen. Accessed January 16, 2021. http://www.theses.fr/2009BOR21699.

MLA Handbook (7th Edition):

Djabarouti, Sarah. “Optimisation des traitements à base d'acide mycophénolique chez les patients atteints de maladies auto-immunes : Strategies for improving treatments with mycophenolic acid in patients with autoimmune diseases.” 2009. Web. 16 Jan 2021.

Vancouver:

Djabarouti S. Optimisation des traitements à base d'acide mycophénolique chez les patients atteints de maladies auto-immunes : Strategies for improving treatments with mycophenolic acid in patients with autoimmune diseases. [Internet] [Doctoral dissertation]. Université de Bordeaux Segalen; 2009. [cited 2021 Jan 16]. Available from: http://www.theses.fr/2009BOR21699.

Council of Science Editors:

Djabarouti S. Optimisation des traitements à base d'acide mycophénolique chez les patients atteints de maladies auto-immunes : Strategies for improving treatments with mycophenolic acid in patients with autoimmune diseases. [Doctoral Dissertation]. Université de Bordeaux Segalen; 2009. Available from: http://www.theses.fr/2009BOR21699


INP Toulouse

8. Pastor, Mélanie. Modélisation pharmacocinétique/pharmacodynamique par une approche de population de l’effet du G-CSF chez des patients traités avec du carboplatine : Population pharmacokinetic/pharmacodynamic modelisation of G-CSF effect in carboplatin-treated patients.

Degree: Docteur es, Pathologie, Toxicologie, Génétique et Nutrition, 2013, INP Toulouse

Une des stratégies pour limiter les neutropénies induites par la chimiothérapie est l’utilisation de granulocyte-colony stimulating factor (G-CSF). Nous avons développé, par une approche de… (more)

Subjects/Keywords: Myélotoxicité; Neutropénie; Chimiothérapie; Granulocyte colony-stimulating factor (G-CSF); Modélisation pharmacocinétique/pharmacodynamique (PK/PD); Carboplatine; Myelotoxicity; Neutropenia; Chemotherapy; Granulocyte colony-stimulating factor (G-CSF); Pharmacokinetic/pharmacodynamic (PK/PD) modeling

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Pastor, M. (2013). Modélisation pharmacocinétique/pharmacodynamique par une approche de population de l’effet du G-CSF chez des patients traités avec du carboplatine : Population pharmacokinetic/pharmacodynamic modelisation of G-CSF effect in carboplatin-treated patients. (Doctoral Dissertation). INP Toulouse. Retrieved from http://www.theses.fr/2013INPT0061

Chicago Manual of Style (16th Edition):

Pastor, Mélanie. “Modélisation pharmacocinétique/pharmacodynamique par une approche de population de l’effet du G-CSF chez des patients traités avec du carboplatine : Population pharmacokinetic/pharmacodynamic modelisation of G-CSF effect in carboplatin-treated patients.” 2013. Doctoral Dissertation, INP Toulouse. Accessed January 16, 2021. http://www.theses.fr/2013INPT0061.

MLA Handbook (7th Edition):

Pastor, Mélanie. “Modélisation pharmacocinétique/pharmacodynamique par une approche de population de l’effet du G-CSF chez des patients traités avec du carboplatine : Population pharmacokinetic/pharmacodynamic modelisation of G-CSF effect in carboplatin-treated patients.” 2013. Web. 16 Jan 2021.

Vancouver:

Pastor M. Modélisation pharmacocinétique/pharmacodynamique par une approche de population de l’effet du G-CSF chez des patients traités avec du carboplatine : Population pharmacokinetic/pharmacodynamic modelisation of G-CSF effect in carboplatin-treated patients. [Internet] [Doctoral dissertation]. INP Toulouse; 2013. [cited 2021 Jan 16]. Available from: http://www.theses.fr/2013INPT0061.

Council of Science Editors:

Pastor M. Modélisation pharmacocinétique/pharmacodynamique par une approche de population de l’effet du G-CSF chez des patients traités avec du carboplatine : Population pharmacokinetic/pharmacodynamic modelisation of G-CSF effect in carboplatin-treated patients. [Doctoral Dissertation]. INP Toulouse; 2013. Available from: http://www.theses.fr/2013INPT0061

9. Mehta, Shachi. Biopharmaceutical optimization of antibiotic therapy for the treatment of Mycobacterium abscessus pulmonary infections : interest of nebulization and antibiotic combinations : Optimisation biopharmaceutique de l'antibiothérapie pour le traitement des infections pulmonaires à Mycobacterium abscessus : intérêt de la nébulisation et des combinaisons antibiotiques.

Degree: Docteur es, Pharmacologie et sciences du médicament, 2019, Poitiers

 Mycobacterium abscessus est une mycobactérie non-tuberculeuse responsable d’infections pulmonaires difficiles à traiter en clinique. Le traitement actuellement recommandé est associé à un taux d’échec élevé… (more)

Subjects/Keywords: Mycobacterium abscessus; Céfoxitine; Amikacine; Modélisation PK/PD; In vitro; Combinaison; Antibiorésistance; Mycobacterium abscessus; Cefoxitin; Amikacin; PK/PD modeling; In vitro; Combination; Antibiotic resistance; 615.792 2

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Mehta, S. (2019). Biopharmaceutical optimization of antibiotic therapy for the treatment of Mycobacterium abscessus pulmonary infections : interest of nebulization and antibiotic combinations : Optimisation biopharmaceutique de l'antibiothérapie pour le traitement des infections pulmonaires à Mycobacterium abscessus : intérêt de la nébulisation et des combinaisons antibiotiques. (Doctoral Dissertation). Poitiers. Retrieved from http://www.theses.fr/2019POIT1805

Chicago Manual of Style (16th Edition):

Mehta, Shachi. “Biopharmaceutical optimization of antibiotic therapy for the treatment of Mycobacterium abscessus pulmonary infections : interest of nebulization and antibiotic combinations : Optimisation biopharmaceutique de l'antibiothérapie pour le traitement des infections pulmonaires à Mycobacterium abscessus : intérêt de la nébulisation et des combinaisons antibiotiques.” 2019. Doctoral Dissertation, Poitiers. Accessed January 16, 2021. http://www.theses.fr/2019POIT1805.

MLA Handbook (7th Edition):

Mehta, Shachi. “Biopharmaceutical optimization of antibiotic therapy for the treatment of Mycobacterium abscessus pulmonary infections : interest of nebulization and antibiotic combinations : Optimisation biopharmaceutique de l'antibiothérapie pour le traitement des infections pulmonaires à Mycobacterium abscessus : intérêt de la nébulisation et des combinaisons antibiotiques.” 2019. Web. 16 Jan 2021.

Vancouver:

Mehta S. Biopharmaceutical optimization of antibiotic therapy for the treatment of Mycobacterium abscessus pulmonary infections : interest of nebulization and antibiotic combinations : Optimisation biopharmaceutique de l'antibiothérapie pour le traitement des infections pulmonaires à Mycobacterium abscessus : intérêt de la nébulisation et des combinaisons antibiotiques. [Internet] [Doctoral dissertation]. Poitiers; 2019. [cited 2021 Jan 16]. Available from: http://www.theses.fr/2019POIT1805.

Council of Science Editors:

Mehta S. Biopharmaceutical optimization of antibiotic therapy for the treatment of Mycobacterium abscessus pulmonary infections : interest of nebulization and antibiotic combinations : Optimisation biopharmaceutique de l'antibiothérapie pour le traitement des infections pulmonaires à Mycobacterium abscessus : intérêt de la nébulisation et des combinaisons antibiotiques. [Doctoral Dissertation]. Poitiers; 2019. Available from: http://www.theses.fr/2019POIT1805

10. 張, 仁美. 日本人血液透析患者に対するレボフロキサシン500mg投与後の血中濃度の検討 : Evaluation of serum through levels after oral administration of high dose Levofloxacin in Japanese hemodialysis patients.

Degree: 博士(医学), 2014, Niigata University / 新潟大学

学位の種類: 博士(医学). 報告番号: 甲第3943号. 学位記番号: 新大院博(医)甲第610号.学位授与年月日: 平成26年9月22日

これまで使用されてきたLevofloxacin (LVFX) 低用量(100mg)製剤に変わって、2009年に発売された500mg、250mg製剤の日本人透析患者における血中濃度、安全性を検討した報告は少ないため、感染症治療のためにLVFXを使用した透析患者に対し、透析前血中トラフ濃度の測定を行い、血液透析患者における血中濃度を確認した。今回9症例を登録し解析した。全例LVFXで感染症の症状は軽快していた。全症例の平均血中トラフ値は3.46±1.42μg/mlであった。500mg単回投与で投与後二日目の透析直前の平均が4.18±1.35μg/mlで、透析間隔の関係により72時間時点で採血した症例では2.93であった。また、複数回投与症例においても最終投与後48時間での血中濃度トラフ値は平均2.17±0.72μg/mlと複数回投与でも薬剤の蓄積傾向はなかった。一方で体重と血中濃度のトラフ値には単回投与群で明確な相関がみられた。LVFX500mg錠発売後、多くの透析患者での使用実績があり透析患者においても重篤な有害事象の報告は少なく安全に使用できる薬剤であるが、透析患者では高齢者、低体重患者も多くPK-PD上の至適用量として減量が可能な症例の有無等さらなるデータ蓄積が望まれる。

Subjects/Keywords: LVFX; 血液透析; 血中トラフ濃度; PK-PD

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

張, . (2014). 日本人血液透析患者に対するレボフロキサシン500mg投与後の血中濃度の検討 : Evaluation of serum through levels after oral administration of high dose Levofloxacin in Japanese hemodialysis patients. (Thesis). Niigata University / 新潟大学. Retrieved from http://hdl.handle.net/10191/30971

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

張, 仁美. “日本人血液透析患者に対するレボフロキサシン500mg投与後の血中濃度の検討 : Evaluation of serum through levels after oral administration of high dose Levofloxacin in Japanese hemodialysis patients.” 2014. Thesis, Niigata University / 新潟大学. Accessed January 16, 2021. http://hdl.handle.net/10191/30971.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

張, 仁美. “日本人血液透析患者に対するレボフロキサシン500mg投与後の血中濃度の検討 : Evaluation of serum through levels after oral administration of high dose Levofloxacin in Japanese hemodialysis patients.” 2014. Web. 16 Jan 2021.

Vancouver:

張 . 日本人血液透析患者に対するレボフロキサシン500mg投与後の血中濃度の検討 : Evaluation of serum through levels after oral administration of high dose Levofloxacin in Japanese hemodialysis patients. [Internet] [Thesis]. Niigata University / 新潟大学; 2014. [cited 2021 Jan 16]. Available from: http://hdl.handle.net/10191/30971.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

張 . 日本人血液透析患者に対するレボフロキサシン500mg投与後の血中濃度の検討 : Evaluation of serum through levels after oral administration of high dose Levofloxacin in Japanese hemodialysis patients. [Thesis]. Niigata University / 新潟大学; 2014. Available from: http://hdl.handle.net/10191/30971

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Temple University

11. Sharma, Jyoti. Intratumoral Pharmacokinetics and Pharmacodynamics of Gefitinib in an Orthotopic Brain Tumor Model.

Degree: PhD, 2013, Temple University

Pharmaceutical Sciences

Glioblastomas are highly vascular brain tumors that are characterized as heterogeneous, comprised of an anatomically and functionally irregular blood brain barrier (BBB) that… (more)

Subjects/Keywords: Pharmaceutical sciences;

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Sharma, J. (2013). Intratumoral Pharmacokinetics and Pharmacodynamics of Gefitinib in an Orthotopic Brain Tumor Model. (Doctoral Dissertation). Temple University. Retrieved from http://digital.library.temple.edu/u?/p245801coll10,228240

Chicago Manual of Style (16th Edition):

Sharma, Jyoti. “Intratumoral Pharmacokinetics and Pharmacodynamics of Gefitinib in an Orthotopic Brain Tumor Model.” 2013. Doctoral Dissertation, Temple University. Accessed January 16, 2021. http://digital.library.temple.edu/u?/p245801coll10,228240.

MLA Handbook (7th Edition):

Sharma, Jyoti. “Intratumoral Pharmacokinetics and Pharmacodynamics of Gefitinib in an Orthotopic Brain Tumor Model.” 2013. Web. 16 Jan 2021.

Vancouver:

Sharma J. Intratumoral Pharmacokinetics and Pharmacodynamics of Gefitinib in an Orthotopic Brain Tumor Model. [Internet] [Doctoral dissertation]. Temple University; 2013. [cited 2021 Jan 16]. Available from: http://digital.library.temple.edu/u?/p245801coll10,228240.

Council of Science Editors:

Sharma J. Intratumoral Pharmacokinetics and Pharmacodynamics of Gefitinib in an Orthotopic Brain Tumor Model. [Doctoral Dissertation]. Temple University; 2013. Available from: http://digital.library.temple.edu/u?/p245801coll10,228240

12. Fors, John. Effectiveness of reduced-dose efavirenz in hiv therapy considering patient adherence.

Degree: Bioscience, 2012, University of Skövde

  Antiretroviral drugs have revolutionized HIV care and enabled better management of the infection thus allowing patients survive for many years. One proposed approach to… (more)

Subjects/Keywords: HIV; antiretroviral; adherence; reduced dose; viral resistance; PK/PD; efavirenz; rifampin; CYP2B6

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Fors, J. (2012). Effectiveness of reduced-dose efavirenz in hiv therapy considering patient adherence. (Thesis). University of Skövde. Retrieved from http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-12739

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Fors, John. “Effectiveness of reduced-dose efavirenz in hiv therapy considering patient adherence.” 2012. Thesis, University of Skövde. Accessed January 16, 2021. http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-12739.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Fors, John. “Effectiveness of reduced-dose efavirenz in hiv therapy considering patient adherence.” 2012. Web. 16 Jan 2021.

Vancouver:

Fors J. Effectiveness of reduced-dose efavirenz in hiv therapy considering patient adherence. [Internet] [Thesis]. University of Skövde; 2012. [cited 2021 Jan 16]. Available from: http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-12739.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Fors J. Effectiveness of reduced-dose efavirenz in hiv therapy considering patient adherence. [Thesis]. University of Skövde; 2012. Available from: http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-12739

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


UCLA

13. Shi, Yu. Using Particle Swarm Optimization to Find Efficient Designs for Mixed Effects Models with Sparse Grid and Predict Progression of Idiopathic Pulmonary Fibrosis using Baseline High Resolution Computed Tomography Scans with Random Forest.

Degree: Biostatistics, 2019, UCLA

 There are many challenging optimization problems in the health sciences. Problems in health sciences are increasingly complex, and frequently the most advanced optimization techniques are… (more)

Subjects/Keywords: Biostatistics; Medical imaging; Interstitial lung disease; Longitudinal optimal designs; Medical imaging; Non-linear mixed effects models; PK/PD studies; Texture features

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Shi, Y. (2019). Using Particle Swarm Optimization to Find Efficient Designs for Mixed Effects Models with Sparse Grid and Predict Progression of Idiopathic Pulmonary Fibrosis using Baseline High Resolution Computed Tomography Scans with Random Forest. (Thesis). UCLA. Retrieved from http://www.escholarship.org/uc/item/0k99z04n

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Shi, Yu. “Using Particle Swarm Optimization to Find Efficient Designs for Mixed Effects Models with Sparse Grid and Predict Progression of Idiopathic Pulmonary Fibrosis using Baseline High Resolution Computed Tomography Scans with Random Forest.” 2019. Thesis, UCLA. Accessed January 16, 2021. http://www.escholarship.org/uc/item/0k99z04n.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Shi, Yu. “Using Particle Swarm Optimization to Find Efficient Designs for Mixed Effects Models with Sparse Grid and Predict Progression of Idiopathic Pulmonary Fibrosis using Baseline High Resolution Computed Tomography Scans with Random Forest.” 2019. Web. 16 Jan 2021.

Vancouver:

Shi Y. Using Particle Swarm Optimization to Find Efficient Designs for Mixed Effects Models with Sparse Grid and Predict Progression of Idiopathic Pulmonary Fibrosis using Baseline High Resolution Computed Tomography Scans with Random Forest. [Internet] [Thesis]. UCLA; 2019. [cited 2021 Jan 16]. Available from: http://www.escholarship.org/uc/item/0k99z04n.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Shi Y. Using Particle Swarm Optimization to Find Efficient Designs for Mixed Effects Models with Sparse Grid and Predict Progression of Idiopathic Pulmonary Fibrosis using Baseline High Resolution Computed Tomography Scans with Random Forest. [Thesis]. UCLA; 2019. Available from: http://www.escholarship.org/uc/item/0k99z04n

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

14. Rezai Gharahbolagh, Keyvan. Variabilité pharmacocinétique des anti-cancéreux : Application à la vinorelbine et au lapatinib : Pharmacokinetic variability of anticancer drugs : application with vinorelbine and lapatinib.

Degree: Docteur es, Pharmacologie, 2012, Université Paris Descartes – Paris V

La mise en évidence de la variabilité pharmacocinétique et/ou pharmacodynamique permet l’optimisation de l’utilisation des cytotoxiques. L’association des thérapies ciblées à la chimiothérapie conventionnelle peut… (more)

Subjects/Keywords: Pharmacocinétique; Pharmacodynamie; Thérapie ciblée; Variabilités Interindividuelles; Modélisation; Pharmacokinetics; Pharmacodynamics; Targeted therapy; Interpatient Variabilities; PK-PD Modeling; 616.994 06

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Rezai Gharahbolagh, K. (2012). Variabilité pharmacocinétique des anti-cancéreux : Application à la vinorelbine et au lapatinib : Pharmacokinetic variability of anticancer drugs : application with vinorelbine and lapatinib. (Doctoral Dissertation). Université Paris Descartes – Paris V. Retrieved from http://www.theses.fr/2012PA05P606

Chicago Manual of Style (16th Edition):

Rezai Gharahbolagh, Keyvan. “Variabilité pharmacocinétique des anti-cancéreux : Application à la vinorelbine et au lapatinib : Pharmacokinetic variability of anticancer drugs : application with vinorelbine and lapatinib.” 2012. Doctoral Dissertation, Université Paris Descartes – Paris V. Accessed January 16, 2021. http://www.theses.fr/2012PA05P606.

MLA Handbook (7th Edition):

Rezai Gharahbolagh, Keyvan. “Variabilité pharmacocinétique des anti-cancéreux : Application à la vinorelbine et au lapatinib : Pharmacokinetic variability of anticancer drugs : application with vinorelbine and lapatinib.” 2012. Web. 16 Jan 2021.

Vancouver:

Rezai Gharahbolagh K. Variabilité pharmacocinétique des anti-cancéreux : Application à la vinorelbine et au lapatinib : Pharmacokinetic variability of anticancer drugs : application with vinorelbine and lapatinib. [Internet] [Doctoral dissertation]. Université Paris Descartes – Paris V; 2012. [cited 2021 Jan 16]. Available from: http://www.theses.fr/2012PA05P606.

Council of Science Editors:

Rezai Gharahbolagh K. Variabilité pharmacocinétique des anti-cancéreux : Application à la vinorelbine et au lapatinib : Pharmacokinetic variability of anticancer drugs : application with vinorelbine and lapatinib. [Doctoral Dissertation]. Université Paris Descartes – Paris V; 2012. Available from: http://www.theses.fr/2012PA05P606


Universidade do Rio Grande do Sul

15. Azeredo, Francine Johansson. Modelagem farmacocinética/farmacodinâmica do antifúngico fluconazol.

Degree: 2013, Universidade do Rio Grande do Sul

 Objetivos: O objetivo deste trabalho foi o estabelecimento de um modelo PK/PD capaz de descrever o efeito fungistático de fluconazol (FCZ) contra diferentes espécies de… (more)

Subjects/Keywords: Fluconazole; Modelagem farmacocinética-farmacodinâmica; Renal microdialysis; Fluconazol; Antifúngicos; Candida spp.; Microdialise; In vitro model infection; PK/PD modeling; Candida

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Azeredo, F. J. (2013). Modelagem farmacocinética/farmacodinâmica do antifúngico fluconazol. (Thesis). Universidade do Rio Grande do Sul. Retrieved from http://hdl.handle.net/10183/72917

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Azeredo, Francine Johansson. “Modelagem farmacocinética/farmacodinâmica do antifúngico fluconazol.” 2013. Thesis, Universidade do Rio Grande do Sul. Accessed January 16, 2021. http://hdl.handle.net/10183/72917.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Azeredo, Francine Johansson. “Modelagem farmacocinética/farmacodinâmica do antifúngico fluconazol.” 2013. Web. 16 Jan 2021.

Vancouver:

Azeredo FJ. Modelagem farmacocinética/farmacodinâmica do antifúngico fluconazol. [Internet] [Thesis]. Universidade do Rio Grande do Sul; 2013. [cited 2021 Jan 16]. Available from: http://hdl.handle.net/10183/72917.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Azeredo FJ. Modelagem farmacocinética/farmacodinâmica do antifúngico fluconazol. [Thesis]. Universidade do Rio Grande do Sul; 2013. Available from: http://hdl.handle.net/10183/72917

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Universidade do Rio Grande do Sul

16. Alves, Izabel Almeida. Modelagem farmacocinética-farmacodinâmica de antifúngicos azólicos em animais infectados por Cryptococcus neoformans.

Degree: 2017, Universidade do Rio Grande do Sul

 O objetivo desta tese foi desenvolver um modelo farmacocinético-farmacodinâmico (PK-PD) aplicável a avaliação de esquemas posológicos de antifúngicos sistêmicos no tratamento de infecções cerebrais associadas… (more)

Subjects/Keywords: Cryptococcus neoformans; Cryptococcus neoformans; Modelagem farmacocinética-farmacodinâmica; Monte Carlo simulation; Antifúngicos; PK-PD modeling; Brain penetration; Microdialysis; Voriconazole; Fluconazole

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Alves, I. A. (2017). Modelagem farmacocinética-farmacodinâmica de antifúngicos azólicos em animais infectados por Cryptococcus neoformans. (Thesis). Universidade do Rio Grande do Sul. Retrieved from http://hdl.handle.net/10183/170662

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Alves, Izabel Almeida. “Modelagem farmacocinética-farmacodinâmica de antifúngicos azólicos em animais infectados por Cryptococcus neoformans.” 2017. Thesis, Universidade do Rio Grande do Sul. Accessed January 16, 2021. http://hdl.handle.net/10183/170662.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Alves, Izabel Almeida. “Modelagem farmacocinética-farmacodinâmica de antifúngicos azólicos em animais infectados por Cryptococcus neoformans.” 2017. Web. 16 Jan 2021.

Vancouver:

Alves IA. Modelagem farmacocinética-farmacodinâmica de antifúngicos azólicos em animais infectados por Cryptococcus neoformans. [Internet] [Thesis]. Universidade do Rio Grande do Sul; 2017. [cited 2021 Jan 16]. Available from: http://hdl.handle.net/10183/170662.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Alves IA. Modelagem farmacocinética-farmacodinâmica de antifúngicos azólicos em animais infectados por Cryptococcus neoformans. [Thesis]. Universidade do Rio Grande do Sul; 2017. Available from: http://hdl.handle.net/10183/170662

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Houston

17. Teng, Yang 1982-. Impacts of Spinal Cord Injury and Formulation on Riluzole Pharmacokinetics and Pharmacokinetics/Pharmacodynamics (PK/PD) Correlation.

Degree: Pharmaceutics, Pharmacological and Pharmaceutical Sciences, University of Houston

 Acute Spinal Cord injury (SCI) is a complex disorder involving a sudden traumatic insult to the cord resulting in deficits to ambulatory, sensory and autonomic… (more)

Subjects/Keywords: Riluzole; Pharmacokinetics; Spinal cord injuries; NONMEM; PK/PD Correlation

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Teng, Y. 1. (n.d.). Impacts of Spinal Cord Injury and Formulation on Riluzole Pharmacokinetics and Pharmacokinetics/Pharmacodynamics (PK/PD) Correlation. (Doctoral Dissertation). University of Houston. Retrieved from http://hdl.handle.net/10657/2974

Note: this citation may be lacking information needed for this citation format:
No year of publication.

Chicago Manual of Style (16th Edition):

Teng, Yang 1982-. “Impacts of Spinal Cord Injury and Formulation on Riluzole Pharmacokinetics and Pharmacokinetics/Pharmacodynamics (PK/PD) Correlation.” Doctoral Dissertation, University of Houston. Accessed January 16, 2021. http://hdl.handle.net/10657/2974.

Note: this citation may be lacking information needed for this citation format:
No year of publication.

MLA Handbook (7th Edition):

Teng, Yang 1982-. “Impacts of Spinal Cord Injury and Formulation on Riluzole Pharmacokinetics and Pharmacokinetics/Pharmacodynamics (PK/PD) Correlation.” Web. 16 Jan 2021.

Note: this citation may be lacking information needed for this citation format:
No year of publication.

Vancouver:

Teng Y1. Impacts of Spinal Cord Injury and Formulation on Riluzole Pharmacokinetics and Pharmacokinetics/Pharmacodynamics (PK/PD) Correlation. [Internet] [Doctoral dissertation]. University of Houston; [cited 2021 Jan 16]. Available from: http://hdl.handle.net/10657/2974.

Note: this citation may be lacking information needed for this citation format:
No year of publication.

Council of Science Editors:

Teng Y1. Impacts of Spinal Cord Injury and Formulation on Riluzole Pharmacokinetics and Pharmacokinetics/Pharmacodynamics (PK/PD) Correlation. [Doctoral Dissertation]. University of Houston; Available from: http://hdl.handle.net/10657/2974

Note: this citation may be lacking information needed for this citation format:
No year of publication.


University of Iowa

18. Xie, Lanyi. Population pharmacokinetic/pharmacodynamic modeling of insulin kinetics.

Degree: PhD, Pharmacy, 2011, University of Iowa

  The development of type 2 diabetes over time involves defects in insulin action and insulin secretion. Defects in insulin action alone can be compensated… (more)

Subjects/Keywords: Beta-cell; First-phase insulin; Glucose tolerance; Insulin modeling; Insulin secretion; Population PK/PD; Pharmacy and Pharmaceutical Sciences

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Xie, L. (2011). Population pharmacokinetic/pharmacodynamic modeling of insulin kinetics. (Doctoral Dissertation). University of Iowa. Retrieved from https://ir.uiowa.edu/etd/2791

Chicago Manual of Style (16th Edition):

Xie, Lanyi. “Population pharmacokinetic/pharmacodynamic modeling of insulin kinetics.” 2011. Doctoral Dissertation, University of Iowa. Accessed January 16, 2021. https://ir.uiowa.edu/etd/2791.

MLA Handbook (7th Edition):

Xie, Lanyi. “Population pharmacokinetic/pharmacodynamic modeling of insulin kinetics.” 2011. Web. 16 Jan 2021.

Vancouver:

Xie L. Population pharmacokinetic/pharmacodynamic modeling of insulin kinetics. [Internet] [Doctoral dissertation]. University of Iowa; 2011. [cited 2021 Jan 16]. Available from: https://ir.uiowa.edu/etd/2791.

Council of Science Editors:

Xie L. Population pharmacokinetic/pharmacodynamic modeling of insulin kinetics. [Doctoral Dissertation]. University of Iowa; 2011. Available from: https://ir.uiowa.edu/etd/2791


University of Iowa

19. Bi, Youwei. Population pharmacokinetic/pharmacodynamic (PK/PD) modeling of depot testosterone cypionate in healthy male subjects.

Degree: PhD, Pharmaceutical Sciences and Experimental Therapeutics, 2016, University of Iowa

  Depot intramuscularly administered testosterone cypionate (TC) is indicated for treatment of hypogonadism in males. However, illegal use of TC and other anabolic steroids in… (more)

Subjects/Keywords: Abuse of steroids; Luteinizing hormone; Population pharmacokinetic/pharmacodynamic (PK/PD) modeling; Spermatogenesis; Testosterone cypionate; Pharmacy and Pharmaceutical Sciences

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Bi, Y. (2016). Population pharmacokinetic/pharmacodynamic (PK/PD) modeling of depot testosterone cypionate in healthy male subjects. (Doctoral Dissertation). University of Iowa. Retrieved from https://ir.uiowa.edu/etd/5716

Chicago Manual of Style (16th Edition):

Bi, Youwei. “Population pharmacokinetic/pharmacodynamic (PK/PD) modeling of depot testosterone cypionate in healthy male subjects.” 2016. Doctoral Dissertation, University of Iowa. Accessed January 16, 2021. https://ir.uiowa.edu/etd/5716.

MLA Handbook (7th Edition):

Bi, Youwei. “Population pharmacokinetic/pharmacodynamic (PK/PD) modeling of depot testosterone cypionate in healthy male subjects.” 2016. Web. 16 Jan 2021.

Vancouver:

Bi Y. Population pharmacokinetic/pharmacodynamic (PK/PD) modeling of depot testosterone cypionate in healthy male subjects. [Internet] [Doctoral dissertation]. University of Iowa; 2016. [cited 2021 Jan 16]. Available from: https://ir.uiowa.edu/etd/5716.

Council of Science Editors:

Bi Y. Population pharmacokinetic/pharmacodynamic (PK/PD) modeling of depot testosterone cypionate in healthy male subjects. [Doctoral Dissertation]. University of Iowa; 2016. Available from: https://ir.uiowa.edu/etd/5716

20. Santos, Verônica Jorge. Modelagem farmacocinética-farmacodinâmica da morfina administrada através de bomba controlada pelo paciente no pós-operatório de revascularização do miocárdio.

Degree: PhD, Produção e Controle Farmacêuticos, 2008, University of São Paulo

Introdução: A administração de morfina através de bomba de infusão controlada pelo paciente (ACP) no tratamento da dor pós-cirurgica e traumática tem-se mostrado promissora e… (more)

Subjects/Keywords: Área sob a curva; Area under the curve; Fármaco; Intensidade da dor pós-operatória; LC-MS/MS (ESI+); LC-MS/MS (ESI+); Modelo PK-PD; Morfina ACP; Morphine PCA; Pharmaco; PK-PD modeling; Postoperative pain

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Santos, V. J. (2008). Modelagem farmacocinética-farmacodinâmica da morfina administrada através de bomba controlada pelo paciente no pós-operatório de revascularização do miocárdio. (Doctoral Dissertation). University of São Paulo. Retrieved from http://www.teses.usp.br/teses/disponiveis/9/9139/tde-05052008-142710/ ;

Chicago Manual of Style (16th Edition):

Santos, Verônica Jorge. “Modelagem farmacocinética-farmacodinâmica da morfina administrada através de bomba controlada pelo paciente no pós-operatório de revascularização do miocárdio.” 2008. Doctoral Dissertation, University of São Paulo. Accessed January 16, 2021. http://www.teses.usp.br/teses/disponiveis/9/9139/tde-05052008-142710/ ;.

MLA Handbook (7th Edition):

Santos, Verônica Jorge. “Modelagem farmacocinética-farmacodinâmica da morfina administrada através de bomba controlada pelo paciente no pós-operatório de revascularização do miocárdio.” 2008. Web. 16 Jan 2021.

Vancouver:

Santos VJ. Modelagem farmacocinética-farmacodinâmica da morfina administrada através de bomba controlada pelo paciente no pós-operatório de revascularização do miocárdio. [Internet] [Doctoral dissertation]. University of São Paulo; 2008. [cited 2021 Jan 16]. Available from: http://www.teses.usp.br/teses/disponiveis/9/9139/tde-05052008-142710/ ;.

Council of Science Editors:

Santos VJ. Modelagem farmacocinética-farmacodinâmica da morfina administrada através de bomba controlada pelo paciente no pós-operatório de revascularização do miocárdio. [Doctoral Dissertation]. University of São Paulo; 2008. Available from: http://www.teses.usp.br/teses/disponiveis/9/9139/tde-05052008-142710/ ;

21. Pierrillas, Philippe. Optimisation du développement clinique de nouveaux anticancéreux par modélisation de données pharmacocinétiques et pharmacodynamiques précliniques : Optimization of new anticancer drugs clinical developement by pharmacokinetic and pharmacodynamic modelling of preclinical data.

Degree: Docteur es, Pharmacométrie, 2016, Lyon

L’amélioration du développement du médicament est un véritable défi et ceci encore plus dans le domaine de l’oncologie dans lequel le besoin d’avoir de nouvelles… (more)

Subjects/Keywords: Approche translationnelle inter-espèces; Développement du médicament; Oncologie; Inhibiteur de bcl-2; Apoptose; Modèle PK-PD; Modèle PBPK; Interspecies translational approach; Drug development; Oncology; Bcl-2 inhibitor; Apoptosis; PK-PD model; PBPK model; 615

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Pierrillas, P. (2016). Optimisation du développement clinique de nouveaux anticancéreux par modélisation de données pharmacocinétiques et pharmacodynamiques précliniques : Optimization of new anticancer drugs clinical developement by pharmacokinetic and pharmacodynamic modelling of preclinical data. (Doctoral Dissertation). Lyon. Retrieved from http://www.theses.fr/2016LYSE1047

Chicago Manual of Style (16th Edition):

Pierrillas, Philippe. “Optimisation du développement clinique de nouveaux anticancéreux par modélisation de données pharmacocinétiques et pharmacodynamiques précliniques : Optimization of new anticancer drugs clinical developement by pharmacokinetic and pharmacodynamic modelling of preclinical data.” 2016. Doctoral Dissertation, Lyon. Accessed January 16, 2021. http://www.theses.fr/2016LYSE1047.

MLA Handbook (7th Edition):

Pierrillas, Philippe. “Optimisation du développement clinique de nouveaux anticancéreux par modélisation de données pharmacocinétiques et pharmacodynamiques précliniques : Optimization of new anticancer drugs clinical developement by pharmacokinetic and pharmacodynamic modelling of preclinical data.” 2016. Web. 16 Jan 2021.

Vancouver:

Pierrillas P. Optimisation du développement clinique de nouveaux anticancéreux par modélisation de données pharmacocinétiques et pharmacodynamiques précliniques : Optimization of new anticancer drugs clinical developement by pharmacokinetic and pharmacodynamic modelling of preclinical data. [Internet] [Doctoral dissertation]. Lyon; 2016. [cited 2021 Jan 16]. Available from: http://www.theses.fr/2016LYSE1047.

Council of Science Editors:

Pierrillas P. Optimisation du développement clinique de nouveaux anticancéreux par modélisation de données pharmacocinétiques et pharmacodynamiques précliniques : Optimization of new anticancer drugs clinical developement by pharmacokinetic and pharmacodynamic modelling of preclinical data. [Doctoral Dissertation]. Lyon; 2016. Available from: http://www.theses.fr/2016LYSE1047

22. Chauzy, Alexia. Evaluation pharmacocinétique/pharmacodynamique in vitro et in vivo de l'association aztréonam-avibactam : In vitro and in vivo pharmacokinetic/pharmacodynamic evaluation of aztreonam-avibactam.

Degree: Docteur es, Pharmacie, 2018, Poitiers

L'augmentation des résistances aux antibiotiques ces dernières années et le faible nombre de nouveaux antibiotiques récemment approuvés ont suscité un intérêt considérable pour les associations… (more)

Subjects/Keywords: Aztréonam; Avibactam; Association β-Lactamine-Inhibiteur de β-Lactamases; Interaction; Microdialyse; Pharmacocinétique; Pharmacodynamique; Modèle PK/PD; Aztréonam; Avibactam; Association β-Lactamine-Inhibiteur de β-Lactamases; Interaction; Microdialyse; Pharmacocinétique; Pharmacodynamique; Modèle PK/PD; 615.792 2; 615.329

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Chauzy, A. (2018). Evaluation pharmacocinétique/pharmacodynamique in vitro et in vivo de l'association aztréonam-avibactam : In vitro and in vivo pharmacokinetic/pharmacodynamic evaluation of aztreonam-avibactam. (Doctoral Dissertation). Poitiers. Retrieved from http://www.theses.fr/2018POIT1802

Chicago Manual of Style (16th Edition):

Chauzy, Alexia. “Evaluation pharmacocinétique/pharmacodynamique in vitro et in vivo de l'association aztréonam-avibactam : In vitro and in vivo pharmacokinetic/pharmacodynamic evaluation of aztreonam-avibactam.” 2018. Doctoral Dissertation, Poitiers. Accessed January 16, 2021. http://www.theses.fr/2018POIT1802.

MLA Handbook (7th Edition):

Chauzy, Alexia. “Evaluation pharmacocinétique/pharmacodynamique in vitro et in vivo de l'association aztréonam-avibactam : In vitro and in vivo pharmacokinetic/pharmacodynamic evaluation of aztreonam-avibactam.” 2018. Web. 16 Jan 2021.

Vancouver:

Chauzy A. Evaluation pharmacocinétique/pharmacodynamique in vitro et in vivo de l'association aztréonam-avibactam : In vitro and in vivo pharmacokinetic/pharmacodynamic evaluation of aztreonam-avibactam. [Internet] [Doctoral dissertation]. Poitiers; 2018. [cited 2021 Jan 16]. Available from: http://www.theses.fr/2018POIT1802.

Council of Science Editors:

Chauzy A. Evaluation pharmacocinétique/pharmacodynamique in vitro et in vivo de l'association aztréonam-avibactam : In vitro and in vivo pharmacokinetic/pharmacodynamic evaluation of aztreonam-avibactam. [Doctoral Dissertation]. Poitiers; 2018. Available from: http://www.theses.fr/2018POIT1802

23. Bouchnita, Anass. Mathematical modelling of blood coagulation and thrombus formation under flow in normal and pathological conditions : Modélisation mathématique de la coagulation sanguine et la formation du thrombus sous l'écoulement dans les conditions normales et pathologiques.

Degree: Docteur es, Physiologie et biologie des organismes. Populations. Interactions, 2017, Lyon; École Mohammadia d'ingénieurs (Rabat, Maroc)

Cette thèse est consacrée à la modélisation mathématique de la coagulation sanguine et de la formation de thrombus dans des conditions normales et pathologiques. La… (more)

Subjects/Keywords: Coagulation sanguine; Formation de caillots dans l'écoulement sanguin; Thrombose; Saignement; Modélisation mathématique; Simulation numérique; Modèles multi-échelles hybrides; Modélisation PK-PD des médicaments anticoagulants; Blood coagulation; Clot formation in blood flow; Thrombosis; Bleeding; Mathematical modelling; Numerical simulation; Hybrid multiscale models; PK-PD modelling of anticoagulant drugs; 570.15

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Bouchnita, A. (2017). Mathematical modelling of blood coagulation and thrombus formation under flow in normal and pathological conditions : Modélisation mathématique de la coagulation sanguine et la formation du thrombus sous l'écoulement dans les conditions normales et pathologiques. (Doctoral Dissertation). Lyon; École Mohammadia d'ingénieurs (Rabat, Maroc). Retrieved from http://www.theses.fr/2017LYSE1300

Chicago Manual of Style (16th Edition):

Bouchnita, Anass. “Mathematical modelling of blood coagulation and thrombus formation under flow in normal and pathological conditions : Modélisation mathématique de la coagulation sanguine et la formation du thrombus sous l'écoulement dans les conditions normales et pathologiques.” 2017. Doctoral Dissertation, Lyon; École Mohammadia d'ingénieurs (Rabat, Maroc). Accessed January 16, 2021. http://www.theses.fr/2017LYSE1300.

MLA Handbook (7th Edition):

Bouchnita, Anass. “Mathematical modelling of blood coagulation and thrombus formation under flow in normal and pathological conditions : Modélisation mathématique de la coagulation sanguine et la formation du thrombus sous l'écoulement dans les conditions normales et pathologiques.” 2017. Web. 16 Jan 2021.

Vancouver:

Bouchnita A. Mathematical modelling of blood coagulation and thrombus formation under flow in normal and pathological conditions : Modélisation mathématique de la coagulation sanguine et la formation du thrombus sous l'écoulement dans les conditions normales et pathologiques. [Internet] [Doctoral dissertation]. Lyon; École Mohammadia d'ingénieurs (Rabat, Maroc); 2017. [cited 2021 Jan 16]. Available from: http://www.theses.fr/2017LYSE1300.

Council of Science Editors:

Bouchnita A. Mathematical modelling of blood coagulation and thrombus formation under flow in normal and pathological conditions : Modélisation mathématique de la coagulation sanguine et la formation du thrombus sous l'écoulement dans les conditions normales et pathologiques. [Doctoral Dissertation]. Lyon; École Mohammadia d'ingénieurs (Rabat, Maroc); 2017. Available from: http://www.theses.fr/2017LYSE1300

24. Brill, Margreke Jantine Eltje. Concepts and applications for evidence-based dosing in morbidly obese patients before and after weight loss surgery.

Degree: 2015, Division of Pharmacology of the Leiden Academic Center for Drug Research (LACDR), Faculty of Science, Leiden University

 Drug concentrations and effects may be different in morbidly obese patients (body mass index > 40 kg/m2). In addition, also such changes may be expected… (more)

Subjects/Keywords: Morbid Obesity; Cefazolin; Midazolam; Bariatric surgery; Microdialysis; PK-PD modeling; Morbid Obesity; Cefazolin; Midazolam; Bariatric surgery; Microdialysis; PK-PD modeling

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Brill, M. J. E. (2015). Concepts and applications for evidence-based dosing in morbidly obese patients before and after weight loss surgery. (Doctoral Dissertation). Division of Pharmacology of the Leiden Academic Center for Drug Research (LACDR), Faculty of Science, Leiden University. Retrieved from http://hdl.handle.net/1887/36511

Chicago Manual of Style (16th Edition):

Brill, Margreke Jantine Eltje. “Concepts and applications for evidence-based dosing in morbidly obese patients before and after weight loss surgery.” 2015. Doctoral Dissertation, Division of Pharmacology of the Leiden Academic Center for Drug Research (LACDR), Faculty of Science, Leiden University. Accessed January 16, 2021. http://hdl.handle.net/1887/36511.

MLA Handbook (7th Edition):

Brill, Margreke Jantine Eltje. “Concepts and applications for evidence-based dosing in morbidly obese patients before and after weight loss surgery.” 2015. Web. 16 Jan 2021.

Vancouver:

Brill MJE. Concepts and applications for evidence-based dosing in morbidly obese patients before and after weight loss surgery. [Internet] [Doctoral dissertation]. Division of Pharmacology of the Leiden Academic Center for Drug Research (LACDR), Faculty of Science, Leiden University; 2015. [cited 2021 Jan 16]. Available from: http://hdl.handle.net/1887/36511.

Council of Science Editors:

Brill MJE. Concepts and applications for evidence-based dosing in morbidly obese patients before and after weight loss surgery. [Doctoral Dissertation]. Division of Pharmacology of the Leiden Academic Center for Drug Research (LACDR), Faculty of Science, Leiden University; 2015. Available from: http://hdl.handle.net/1887/36511

25. Aranzana-Climent, Vincent. Apport de la modélisation semi-mécanistique dans l'étude pharmacocinétique/pharmacodynamique des antibiotiques seuls et en combinaison dans la lutte contre les bactéries résistantes : Contribution of semi-mechanistic modelling to pharmacokinetic/pharmacodynamic studies of antibiotics alone and in combination in the fight against resistant bacteria.

Degree: Docteur es, Pharmacologie et sciences du médicament, 2019, Poitiers

La lutte contre les bactéries multirésistantes est une priorité majeure définie par l’Organisation Mondiale de la Santé, puisque les dernières prédictions estiment que les infections… (more)

Subjects/Keywords: Céfoxitine; Polymyxine B; Minocycline; Mycobacterium absscessus; Acinetobacter baumannii; Modélisation PK/PD; Pharmacocinétique; Pharmacodynamie; Combinaison; Cefoxitin; Polymyxin B; Minocycline; Mycobacterium abscessus; Acinetobacter baumannii; PK/PD modelling; Pharmacokinetics; Pharmacodynamics; Combination; 615.329; 615.792 2

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Aranzana-Climent, V. (2019). Apport de la modélisation semi-mécanistique dans l'étude pharmacocinétique/pharmacodynamique des antibiotiques seuls et en combinaison dans la lutte contre les bactéries résistantes : Contribution of semi-mechanistic modelling to pharmacokinetic/pharmacodynamic studies of antibiotics alone and in combination in the fight against resistant bacteria. (Doctoral Dissertation). Poitiers. Retrieved from http://www.theses.fr/2019POIT1802

Chicago Manual of Style (16th Edition):

Aranzana-Climent, Vincent. “Apport de la modélisation semi-mécanistique dans l'étude pharmacocinétique/pharmacodynamique des antibiotiques seuls et en combinaison dans la lutte contre les bactéries résistantes : Contribution of semi-mechanistic modelling to pharmacokinetic/pharmacodynamic studies of antibiotics alone and in combination in the fight against resistant bacteria.” 2019. Doctoral Dissertation, Poitiers. Accessed January 16, 2021. http://www.theses.fr/2019POIT1802.

MLA Handbook (7th Edition):

Aranzana-Climent, Vincent. “Apport de la modélisation semi-mécanistique dans l'étude pharmacocinétique/pharmacodynamique des antibiotiques seuls et en combinaison dans la lutte contre les bactéries résistantes : Contribution of semi-mechanistic modelling to pharmacokinetic/pharmacodynamic studies of antibiotics alone and in combination in the fight against resistant bacteria.” 2019. Web. 16 Jan 2021.

Vancouver:

Aranzana-Climent V. Apport de la modélisation semi-mécanistique dans l'étude pharmacocinétique/pharmacodynamique des antibiotiques seuls et en combinaison dans la lutte contre les bactéries résistantes : Contribution of semi-mechanistic modelling to pharmacokinetic/pharmacodynamic studies of antibiotics alone and in combination in the fight against resistant bacteria. [Internet] [Doctoral dissertation]. Poitiers; 2019. [cited 2021 Jan 16]. Available from: http://www.theses.fr/2019POIT1802.

Council of Science Editors:

Aranzana-Climent V. Apport de la modélisation semi-mécanistique dans l'étude pharmacocinétique/pharmacodynamique des antibiotiques seuls et en combinaison dans la lutte contre les bactéries résistantes : Contribution of semi-mechanistic modelling to pharmacokinetic/pharmacodynamic studies of antibiotics alone and in combination in the fight against resistant bacteria. [Doctoral Dissertation]. Poitiers; 2019. Available from: http://www.theses.fr/2019POIT1802

26. Maas, Hugo J. A Markov approach to characterising the PK-PD relationship of anti-migraine drugs.

Degree: 2007, Division of Pharmacology / Leiden-Amsterdam Center for Drug Research, Faculty of Science, Leiden University

 The objective of the investigations described in this thesis was the development of novel PK-PD modelling for the characterisation and prediction of the effects of… (more)

Subjects/Keywords: Headache; Markov chains; Migraine; Naratripta; PK-PD modelling; Sumatriptan; Headache; Markov chains; Migraine; Naratripta; PK-PD modelling; Sumatriptan

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Maas, H. J. (2007). A Markov approach to characterising the PK-PD relationship of anti-migraine drugs. (Doctoral Dissertation). Division of Pharmacology / Leiden-Amsterdam Center for Drug Research, Faculty of Science, Leiden University. Retrieved from http://hdl.handle.net/1887/12040

Chicago Manual of Style (16th Edition):

Maas, Hugo J. “A Markov approach to characterising the PK-PD relationship of anti-migraine drugs.” 2007. Doctoral Dissertation, Division of Pharmacology / Leiden-Amsterdam Center for Drug Research, Faculty of Science, Leiden University. Accessed January 16, 2021. http://hdl.handle.net/1887/12040.

MLA Handbook (7th Edition):

Maas, Hugo J. “A Markov approach to characterising the PK-PD relationship of anti-migraine drugs.” 2007. Web. 16 Jan 2021.

Vancouver:

Maas HJ. A Markov approach to characterising the PK-PD relationship of anti-migraine drugs. [Internet] [Doctoral dissertation]. Division of Pharmacology / Leiden-Amsterdam Center for Drug Research, Faculty of Science, Leiden University; 2007. [cited 2021 Jan 16]. Available from: http://hdl.handle.net/1887/12040.

Council of Science Editors:

Maas HJ. A Markov approach to characterising the PK-PD relationship of anti-migraine drugs. [Doctoral Dissertation]. Division of Pharmacology / Leiden-Amsterdam Center for Drug Research, Faculty of Science, Leiden University; 2007. Available from: http://hdl.handle.net/1887/12040

27. Ackaert, Oliver. Transdermal iontophoresis of dopaminergic (pro) drugs: from formulation to in vivo application.

Degree: 2010, Faculty of Science, Leiden University

 Parkinson’s disease (PD) is an age-related neurodegenerative disorder. Pharmacotherapy is the first line symptomatic treatment of this neurological disease. Currently Levodopa (L-DOPA) is still considered… (more)

Subjects/Keywords: Dopamine agonists; Drug delivery; Parkinson's disease; Percutaneous; PK-PD modeling; Dopamine agonists; Drug delivery; Parkinson's disease; Percutaneous; PK-PD modeling

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Ackaert, O. (2010). Transdermal iontophoresis of dopaminergic (pro) drugs: from formulation to in vivo application. (Doctoral Dissertation). Faculty of Science, Leiden University. Retrieved from http://hdl.handle.net/1887/15336

Chicago Manual of Style (16th Edition):

Ackaert, Oliver. “Transdermal iontophoresis of dopaminergic (pro) drugs: from formulation to in vivo application.” 2010. Doctoral Dissertation, Faculty of Science, Leiden University. Accessed January 16, 2021. http://hdl.handle.net/1887/15336.

MLA Handbook (7th Edition):

Ackaert, Oliver. “Transdermal iontophoresis of dopaminergic (pro) drugs: from formulation to in vivo application.” 2010. Web. 16 Jan 2021.

Vancouver:

Ackaert O. Transdermal iontophoresis of dopaminergic (pro) drugs: from formulation to in vivo application. [Internet] [Doctoral dissertation]. Faculty of Science, Leiden University; 2010. [cited 2021 Jan 16]. Available from: http://hdl.handle.net/1887/15336.

Council of Science Editors:

Ackaert O. Transdermal iontophoresis of dopaminergic (pro) drugs: from formulation to in vivo application. [Doctoral Dissertation]. Faculty of Science, Leiden University; 2010. Available from: http://hdl.handle.net/1887/15336

28. Noppers, Ingeborg Marieke. Safety-efficacy balance of S-ketamine and S-norketamine in acute and chronic pain.

Degree: 2011, Department of Anesthesiology, Faculty of Medicine / Leiden University Medical Center (LUMC), Leiden University

 The balance between safety and efficacy is important in pharmacotherapy. When the indication of a registered drug shifts to another disease or a different patient… (more)

Subjects/Keywords: CRPS; Fibromyalgia; Ketamine; Norketamine; Pain; PK-PD; CRPS; Fibromyalgia; Ketamine; Norketamine; Pain; PK-PD

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Noppers, I. M. (2011). Safety-efficacy balance of S-ketamine and S-norketamine in acute and chronic pain. (Doctoral Dissertation). Department of Anesthesiology, Faculty of Medicine / Leiden University Medical Center (LUMC), Leiden University. Retrieved from http://hdl.handle.net/1887/17811

Chicago Manual of Style (16th Edition):

Noppers, Ingeborg Marieke. “Safety-efficacy balance of S-ketamine and S-norketamine in acute and chronic pain.” 2011. Doctoral Dissertation, Department of Anesthesiology, Faculty of Medicine / Leiden University Medical Center (LUMC), Leiden University. Accessed January 16, 2021. http://hdl.handle.net/1887/17811.

MLA Handbook (7th Edition):

Noppers, Ingeborg Marieke. “Safety-efficacy balance of S-ketamine and S-norketamine in acute and chronic pain.” 2011. Web. 16 Jan 2021.

Vancouver:

Noppers IM. Safety-efficacy balance of S-ketamine and S-norketamine in acute and chronic pain. [Internet] [Doctoral dissertation]. Department of Anesthesiology, Faculty of Medicine / Leiden University Medical Center (LUMC), Leiden University; 2011. [cited 2021 Jan 16]. Available from: http://hdl.handle.net/1887/17811.

Council of Science Editors:

Noppers IM. Safety-efficacy balance of S-ketamine and S-norketamine in acute and chronic pain. [Doctoral Dissertation]. Department of Anesthesiology, Faculty of Medicine / Leiden University Medical Center (LUMC), Leiden University; 2011. Available from: http://hdl.handle.net/1887/17811


Universidade do Rio Grande do Sul

29. Hurtado, Felipe Kellermann. Modelagem pk/pd das fluoroquinolonas levofloxacino e moxifloxacino visando o tratamento da prostatite.

Degree: 2014, Universidade do Rio Grande do Sul

 Objetivo: O objetivo geral deste trabalho foi desenvolver um modelo farmacocinético/farmacodinâmico (PK/PD) para descrever o efeito bactericida in vitro das fluoroquinolonas levofloxacino (LEV) e moxifloxacino… (more)

Subjects/Keywords: Antimicrobials; Modelagem farmacocinética-farmacodinâmica; Prostatitis; Fluoroquinolonas; Levofloxacino; Fluoroquinolones; Levofloxacin; Moxifloxacino; Prostatite; Moxifloxacin; Microdialysis; Pharmacokinetics; PK/PD modeling; Escherichia coli; Time-kill curves

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Hurtado, F. K. (2014). Modelagem pk/pd das fluoroquinolonas levofloxacino e moxifloxacino visando o tratamento da prostatite. (Thesis). Universidade do Rio Grande do Sul. Retrieved from http://hdl.handle.net/10183/99003

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Hurtado, Felipe Kellermann. “Modelagem pk/pd das fluoroquinolonas levofloxacino e moxifloxacino visando o tratamento da prostatite.” 2014. Thesis, Universidade do Rio Grande do Sul. Accessed January 16, 2021. http://hdl.handle.net/10183/99003.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Hurtado, Felipe Kellermann. “Modelagem pk/pd das fluoroquinolonas levofloxacino e moxifloxacino visando o tratamento da prostatite.” 2014. Web. 16 Jan 2021.

Vancouver:

Hurtado FK. Modelagem pk/pd das fluoroquinolonas levofloxacino e moxifloxacino visando o tratamento da prostatite. [Internet] [Thesis]. Universidade do Rio Grande do Sul; 2014. [cited 2021 Jan 16]. Available from: http://hdl.handle.net/10183/99003.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Hurtado FK. Modelagem pk/pd das fluoroquinolonas levofloxacino e moxifloxacino visando o tratamento da prostatite. [Thesis]. Universidade do Rio Grande do Sul; 2014. Available from: http://hdl.handle.net/10183/99003

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Universidade do Rio Grande do Sul

30. Tasso, Leandro. Modelagem farmacocinética-farmacodînâmica das fluorquinolonas levofloxacino e gatifloxacino.

Degree: 2008, Universidade do Rio Grande do Sul

 Objetivo: O objetivo geral deste trabalho foi estabelecer modelo farmacocinéticofarmacodinâmico (modelo PK/PD) para descrever o perfil temporal do efeito bactericida do levofloxacino e do gatifloxacino… (more)

Subjects/Keywords: Modelagem farmacocinética-farmacodinâmica; Levofloxacin; Gatifloxacin; Fluoroquinolonas; Lung microdialysis; Gatifloxacino; PK/PD modeling; Levofloxacino; In vitro infection model; Microdialise; Modelo de infecção in vitro; Validação : Métodos de análise de fármacos

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Tasso, L. (2008). Modelagem farmacocinética-farmacodînâmica das fluorquinolonas levofloxacino e gatifloxacino. (Thesis). Universidade do Rio Grande do Sul. Retrieved from http://hdl.handle.net/10183/13727

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Tasso, Leandro. “Modelagem farmacocinética-farmacodînâmica das fluorquinolonas levofloxacino e gatifloxacino.” 2008. Thesis, Universidade do Rio Grande do Sul. Accessed January 16, 2021. http://hdl.handle.net/10183/13727.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Tasso, Leandro. “Modelagem farmacocinética-farmacodînâmica das fluorquinolonas levofloxacino e gatifloxacino.” 2008. Web. 16 Jan 2021.

Vancouver:

Tasso L. Modelagem farmacocinética-farmacodînâmica das fluorquinolonas levofloxacino e gatifloxacino. [Internet] [Thesis]. Universidade do Rio Grande do Sul; 2008. [cited 2021 Jan 16]. Available from: http://hdl.handle.net/10183/13727.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Tasso L. Modelagem farmacocinética-farmacodînâmica das fluorquinolonas levofloxacino e gatifloxacino. [Thesis]. Universidade do Rio Grande do Sul; 2008. Available from: http://hdl.handle.net/10183/13727

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

[1] [2] [3] [4] [5] … [34]

.